Effects of ceramide analogs on myelinating organ cultures by Benjamins, Joyce A. et al.
Brain Research, 102 (1976) 267-281 267 
© Elsevier Scientific Publishing Company, Amsterdam - Printed in The Netherlands 
EFFECTS OF CERAMIDE ANALOGS ON M Y E L I N A T I N G  ORGAN CUL- 
TURES 
JOYCE A. BENJAMINS*,  JOHN FITCH AND N O R M A N  S. RADIN 
Department of  Neurology, Johns Hopkins University School of  Medicine, Baltimore, Md. 21205 and 
Mental Health Research Institute and Department of  Biological Chemistry, University of  Michigan. Ann 
Arbor, Mich. 48104 (U.S.A.) 
(Accepted July 11 th, 1975) 
SUMMARY 
Analogs of ceramide which inhibit galactocerebrosidase also demyelinate or 
inhibit myelination in organ cultures of rat cerebellum. The potency of the analogs 
in culture correlated with their effectiveness as inhibitors of cerebrosidase, but not 
with their effectiveness as inhibitors of galactosyl transferase. The most effective 
compound was the decanoyl amide of 3-phenyl-2-amino-l,3-propanediol with erythro- 
conformation. Stimulators of cerebrosidase also demyelinated cultures. With both 
groups of compounds, myelin sheaths became distorted, then broke into lipid 
droplets. Axons were preserved, but neurons showed some nuclear changes and 
granularity. Metabolic studies with the most effective inhibitor showed that glucose 
incorporation into cerebroside and other alkali-stable lipids was initially depressed 
compared to proteins and total lipids. 
INTRODUCTION 
Arora, Lin and Radin have synthesized compounds, some of which inhibit 1,3 
and some of which stimulate 4 the degradative enzyme galactosyl ceramide fl-galacto- 
sidase (cerebrosidase). These compounds are of general interest because they are 
among the first analogs available to interfere with specific steps of galactolipid 
metabolism. The compounds are of special interest because the enzyme they affect 
is markedly decreased in Krabbe's disease 21, a dysmyelinating disorder. Thus, the 
inhibitors may provide a unique opportunity to examine mechanisms by which 
* Present address and address for reprints: Department of Neurology, Wayne State University 
School of Medicine, Detroit, Mich. 48201, U.S.A. 
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decreased levels of a dcgradative enzyme lead to pathologic changes in the ncr~(~tJs 
system l~;. 
We examined these compounds in myelinating organ cultures of rat cerebellum 
where direct application ol the analogs and observation of the cultures was possible. 
We asked tile following questions. 
(I) Is the ability of ~m analog to demyelinate or inhibit myelination related to 
its in vitro effect on cerebrosidase? 
(2) When demyelination occurs, is there preservation of axons and neurons? 
(3) Is metabolism of cerebroside in fact affected in the organ cultures'? 
(4) Do other metabolic changes occur and if so, what is their temporal relation- 
ship to the changes in cerebroside metabolism? 
MATERIALS A N D  M E T H O D S  
Analogs 
Three series of compounds synthesized by Arora and Radin 3,4 were screened 
in the organ cultures. The first two series were (1) hydroxy- and (2) non-hydroxy- 
analogs of ceramide which inhibited cerebrosidase 3. The third series included N-acyl 
derivatives of 2-amino-2-methyl-l-propanol, several of which stimulated cerebrosi- 
dasO. The structures of the compounds tested are shown in Tables 1 and II. The 
synthetic analogs were stored desiccated at --20 °C until use. Analogs were dissolved 
in chloroform-methanol and the desired aliquots were transferred to sterile glass 
screwtop tubes and dried with nitrogen at room temperature. Nutrient medium was 
added, and the mixture was sonicated for 5-10 rain in a water-bath sonicator until 
clear. With analogs containing longer chain fatty acids, a fine cloudy suspension 
resulted. 
Preparation and maintenance of cultures 
The methods for preparing and maintaining organ cultures from rat cerebellum 
were essentially those of Bornstein and Murray 7 as modified by SilberberglSa"L 
Newborn Sprague-Dawley rats, less than 24 h old, were anesthetized by exposure to 
cold (--20 °C for 7 rain). The cerebellum was removed, stripped of meninges, and 
cut into 9-10 fragments. Each fragment was placed on a collagen-coated coverslip 
in a 35 mm x ]0 mm plastic tissue culture dish. About 0.4 ml of nutrient medium 
was added to each dish. The routine maintenance nutrient medium was 20 ~ Earle's 
minimal essential medium, 40 ~ (v/v) Earle's balanced salt solution (BSS), and 40 o~ 
(v/v) fetal calf serum (Microbiological Associates, Bethesda, Md.) supplemented with 
glucose to 6 mg/ml, 0.4 units of  zinc-free insulin/ml (a gift of Squibb Institute for 
Medical Research, New Brunswick, N.J.), 0 .002~ phenol red, and 1.7 #g/ml tetra- 
cycline. In some experiments, l0 mM HEPES buffer was included in all media. The 
cultures were maintained at 34.5 °C in a CO2 incubator and fed twice weekly. 
Four days before addition of  analogs, cultures were transferred from plastic 
dishes to the Maximow slide assemblies described by Bornstein and Murray 7. These 
assemblies require smaller amounts of medium and allow more detailed observation 
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of the cultures. Cultures were selected for histological normalcy, then divided random- 
ly into control and experimental groups, so that the control group contained cultures 
from several animals. 
In each experiment, 4-10 control cultures were observed~with the experimental 
cultures from the same explant. Cultures were observed and photographed at various 
times after addition of analogs. For  histology, selected cultures were fixed in buffered 
formalin and stained as whole mounts with a modified Holmes silver impregnation z2. 
To determine whether a compound demyelinated cultures, we transferred well- 
myelinated cultures to Maximow assemblies at 15 days in vitro (DIV), then fed the 
cultures normal or experimental medium at 18-19 DIV. The cultures were observed 
at 4-8 h intervals. In the control groups, spontaneous demyelination was rarely 
observed; 249 of the 256 control cultures remained well-myelinated throughout the 
experimental period. A well-myelinated culture was one which had 20 or more visible 
myelinated axons (Fig. la, b). Cultures were considered demyelinated when (a) no 
myelin was visible, (b) the number of myelinated axons decreased to less than three- 
fourths, or (c) all of the myelin was grossly lumpy and irregular. 
To determine whether a compound inhibited myelin formation, we transferred 
cultures to Maximow assemblies at 4 DIV, then substituted the normal medium with 
experimental medium at 8-9 DIV. Control cultures were fed the normal medium. 
Cultures were observed for several days to determine whether myelination occurred. 
In the controls, 52 of 55 cultures myelinated between 10 and 12 D1V. 
Glucose incorporation 
For measurement of glucose incorporation in myelinated cultures, 19-day-old 
cultures were exposed to D-[U-14C]glucose for 4-48 h. Control and experimental 
cultures were each fed 20 /~1 of medium containing 1 /~Ci of radioactive glucose, 
spec. act. 1.8 mCi/mmole (New England Nuclear, Boston, Mass.). To stop incorpo- 
ration, we washed the cultures twice for 15 min in 10 ml of cold BSS, then scraped 
the cultures from the cover slips into tubes containing 1 ml of 0.32 M sucrose. Gener- 
ally, 5-10 cultures were pooled for each time point and frozen at --20 °C for 1-10 
days before extraction. 
The pooled cultures were homogenized in a power-driven glass-to-glass homo- 
genizer, then mixed with 0.2 ml of a 20~o (w/v) homogenate of cerebellum from a 
19 day rat to minimize losses during extraction. Aliquots of 50 #1 were removed and 
mixed with 10 ml of Aquasol (New England Nuclear, Boston, Mass.) for measure- 
ment of total radioactivity. For lipid extraction, each homogenate was mixed with 
12 Vol. (24 ml) of chloroform-methanol (1:1), 150 #g of cerebroside, 150 /~g of 
sulfatide, and 6C00 counts/min of [6-3H]cerebroside prepared by the borohydride 
procedure 15. After 60 rain at room temperature, the samples were centrifuged at 
1500 rev./min for 10 min, the supernatant was removed, and the remaining pellet 
was washed with 3 ml of chloroform-methanol.  The pellet was transferred to a 
counting vial with several washes of chloroform-methanol. The solvent was evapo- 
rated and the residue was dissolved in 1 ml of NCS (Nuclear Chicago, Des Plaines, 
Ill.), with heating to 50 °C when necessary. Toluene scintillation solvent and a drop 
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TABLE I 




Y NH X 
C - O  
[ 
R 
Amide Structure % Inhibition* 
(0.3 mM)  
X (I)  - Y (3) R Configuration 
1 H OH C9H19 DL-erythro 3 
2 H OH C15Hzl DL-erythro 0 
3 OH H C9H19 L-form 18 
4"* OH OH C9H19 oL-erythro 26 
5 OH OH C9H19 oL-erythro 48 
6 OH H CHO H C1 4 H 2 9  L-form 36 
7 OH OH CHOHC14H~9 DL-erythro 54 
* From previous studies by Arora and Radin 1,:~. 
** P-NOa group on phenyl ring. 
of SnC12 in 0.1 N HCI were added, and radioactivity was measured. The pellet con- 
tains primarily proteins and nucleic acids. 
The combined chloroform-methanol supernatants were partitioned by adding 
chloroform and 0 .74~ KCI containing 5)/o glucose, mixing well, and centrifuging 
for 10 min at 1500 rev./min. One milliliter of the upper phase was mixed with 10 mt 
of Aquasol for measurement of soluble radioactivity. The lower phase was washed 
3 times with 0.2 Vol. of theoretical upper phase. A portion of the washed lower 
phase was removed for measurement of total lipid radioactivity. In preliminary 
experiments, we evaporated the lower phase to dryness, extracted the residue 3 times 
with chloroform-methanol to redissolve the lipids, and measured the radioactivity 
in the residue (presumably some of the proteolipid protein which has been denatured). 
The residue contained less than 1% of the total lower phase counts, so the evaporation 
step was routinely omitted. 
The remaining washed lower phase was subjected to alkaline cleavage to degrade 
phospholipids 10. Portions of the resulting washed lower phase were used for the 
measurement of radioactivity or for separation by thin-layer chromatography in 
chloroform-methanol-H20 (65:25:4). The carrier cerebroside and sulfatide were 
visualized by brief exposure to iodine. Each lane was divided into 8-12 areas which 
were scraped directly into vials for counting by addition of  toluene scintillation 
solvent. Recovery of [14C]cerebroside was determined from the recovery of [3H]- 
cerebroside. 
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TABLE II  




Z - - C - - C ~ I  2OH 
1 
N H  
I 




A m i d e  --  Z R %St imula t ion  
(0.3 m M )  * 
8 H C9H19 0 
9 CH3 C17H35 10 
10 CH3 C15H31 15 
11 CHz C13H27 28 
12 CH3 CllH23 29 
13 CH3 C9H19 55 
* From previous studies by Arora  and Radin 4. 
RESULTS 
Effects of inhibitors of cerebrosidase 
From the series of aromatic amides synthesized from 3-phenyl-2-amino-l,3- 
propanediol and tested by Arora and Radin 3, the best inhibitors of cerebrosidase 
were the analogs with a DL-erythro-l,3-propanediol grouping 3, which resembles 
sphingosine stereochemically (Table I). Compounds with a hydroxyl group at position 
1 alone retained some inhibitory activity, while compounds with a hydroxyl group 
at position 3 alone were inactive 3. 
The most effective inhibitors of cerebrosidase in vitro, the 1,3-propanediol 
analogs, were also the most potent compounds in demyelinating cultures or inhibiting 
myelination (Table Ill). The l-hydroxy compound we tested (amide 3) demyelinated 
only 1 out of 10 cultures during the 48 h they were observed, but effectively inhibited 
myelination in younger cultures. The two analogs with a 3-hydroxyl group (amides 
1 and 2) did not demyelinate or inhibit myelination. 
The ability of the most potent compound, a 1,3-propanediol analog, amide 5, 
to demyelinate organ cultures was examined in more detail. The lower the concen- 
tration of the analog, the longer before demyelination occurred: more than 96 h at 
0.3 raM, compared to 24 h at 3.0 raM. 
Two compounds similar to the analogs described above except that they con- 
tained a-hydroxy hexadecanoic acid were also tested in the cultures (Table I). Again, 
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TABLE 111 
EFFECTS OF INHIBITORS OF (;AI AUT()('EREBROSIDASl~ ON CULTURES 
Cultures were observed at 4--8 h intervals alter addition of new medium (controls) or medium con- 
taining inhibitor. Ratios show number of cultures exhibiting demyelination or lack of myelination 
(0/8 means all 8 cultures myelinated) compared to the total number of cultures exposed to the in- 
hibitor. Data in parentheses show the average time when demyelination occurred. In the inhibition 
experiments, cultures containing inhibitors were last observed on 14-15 DIV, 48 -7211 after all of the 
control cultures had myelinated. Data for demyelination are sums of 2--4 experiments, for inhibition 
of myelination, 2, 
Amide Demyelination ratk~ Myelination 
. . . . . . . . . . . . .  inhibition ratio 
( I m M  amide) (3 mMarnide)  (0.3 m M  amide) 
1 (3-OH) 0/5 (48 h) 
2 (3-OH) 0/3 (48 h) 3/27(48 h) 0/8 
3 (I-OH) 0/3 (48 h) 1/10(48 h) 6/16 
4 (diol) 20/32 (12 h)* 15/15 
5 (diol) 15/22 (48 h) 17/20 (24 h) 8/8** 
6 (I-OH) 1/4 (48 h) 2/8 
7 (diol) 24/32 (48 h) 8/8 
* Myelin in remaining cultures distorted and lumpy. 
** Lethal to cultures by 24 h after addition of analog. 
the 1,3-propanediol derivative was more damaging to the cultures than the analog 
with the hydroxyl group in the 1-position alone. 
Cultures exposed to analogs which demyelinated showed the following course 
of  degeneration by bright-field microscopy. 
(a) At an early stage of demyelination, myelin appeared lumpy and distorted, 
but still largely intact (Fig. lc). Many normal-appearing neurons were evident 
(Fig. ld). Some swollen cells with clear watery cytoplasm, diffuse refractile granules 
and clumped acentric nuclei began to appear. These cells were tentatively identified 
as glial cells since they contained small nuclei and no Nissl substance. 
(b) Myelin then became more distorted, and broke into myelin balls and lipid 
droplets (Fig. le). The number  of intact myelin sheaths was markedly reduced. More 
watery swollen cells appeared. Large neurons began to appear granular (Fig. l f), 
but swelling was rarely noted. The neuronal nuclei appeared normal, but were some- 
times difficult to see because of the granular cytoplasm. 
(c) At late stages of  demyelination, few if any intact myelin sheaths could be 
found. Many lipid droplets accumulated, Neurons showed some evidence of swelling, 
with granular acentric nuclei and perinuclear Nissl substance. Axon preservation 
was observed at this stage (Fig. 2), 
Cultures exposed to analogs which inhibited myelination appeared similar to 
the controls except for absence of myelin and some granularity. The neurons appeared 
healthy. The one exception was amide 5 (Table IV) which appeared toxic to tile 
whole culture; in older cultures, this toxic effect was not observed. 
Fig. 1. Bright-field micrographs of living cultures during demyelination by amide 5 (1 raM) × 800, 
original magnification, a: well-myelinated control culture, 18 DIV. b: neurons in another control 
culture, c: another culture 6 h after addition of cerebrosidase inhibitor amide 5. d: normal appearing 
neurons in the same culture, e: intermediate stage of demyelination, 48 h after addition of amide 5, 
with formation of lipid droplets, f: granular neurons in another culture, 48 h after addition of amide 5. 
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Fig. 2. Axons in control and demyelinated cultures, 19 DI V (modified Holmes silver stain), a: control 
culture. ~ 100, original magnification, b: same culture. 400, original magnification, c: another 
culture demyelinated by amide 5 ~1 raM), with normal appearing axons, t00, original magnifica- 
tion. d: same culture, 400, original magnification. 
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TABLE IV 
EFFECT OF STIMULATORS OF GALACTOCEREBROS1DASE ON CULTURES 
The cultures were exposed to stimulators and observed as described in Table 111. Ratios show number 
of cultures exhibiting demyelination or lack of myelination compared to the total number of cultures 
exposed to the stimulator. Data in parentheses show the average time when demyelination occurred. 
The data for demyelination with amides 9, 10, 11 and 13 are from a single typical experiment; the 
data for amide 12 is the sum of results from the above experiment plus two other experiments in which 
it was compared with amide 8. The inhibition experiments were done with a single batch of cultures, 
and were last observed on 14-15 DIV, 72 h after all of the control cultures had myelinated. 
Amide  Demyelination ra t io  Myelination inhibition ratio 
(3 mM amide) (0.3 mM amide) 
8 11/11 (10h) 
9 0/8 (60h) 0/8 
10 1/8 (36h) 
7/8 (60h) 1/15 
11 3/8 (12h)* 2/12 
12 14/20 (10 h)* 2/4 
13 7/7 (9h)  3/6 
* Myelin in remaining cultures distorted and lumpy. 
Effects of stimulators of cerebrosidase with fatty acids of differing chain lengths 
Aliphatic derivatives of 2-amino-2-metbyl propanol stimulated the activity of 
cerebrosidase when tested in vitro4; the N-decanoyl derivative was the most effective 
(Table If). 
We noted good correlation between the reported potency of these homologs to 
stimulate cerebrosidase and their ability to demyelinate or inhibit myelination in 
organ cultures (Table IV). The decanoyl derivative demyelinated more rapidly than 
those with longer chain fatty acids. When the methyl group on the 2-position was 
omitted (amide 8), the analog had no stimulatory effect on cerebrosidase activity 4. 
However, amide 8 at 3 mM consistently demyelinated cultures within 10 h while 
control cultures remained normal for several days. At present we have no explanation 
for this discrepancy; perhaps this analog has a toxic irnpurity or exerts some unknown 
metabolic effect. 
Metabolic studies 
In control cultures, glucose incorporation into non-lipid material (chloroform- 
methanol insoluble pellet) and into the total lipid fraction was rapid between 0 and 
4 h, then somewhat slower between 8 and 36 h (Fig. 3). Glucose incorporation in 
cultures containing one of the most potent inhibitors of cerebrosidase, amide 5, 
showed an initial stimulation, then depression of non-lipid labeling (Fig. 3). Incorpo- 
ration of glucose into total lipids was depressed by 4 h, and remained depressed. 
The 1 mM concentration of analog depressed glucose incorporation to a greater 
extent than did the 0.3 m M  concentration. Incorporation of glucose into cerebroside 
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Fig. 3. Time-course of  glucose incorporation into non-lipid, lipid and cerebroside fractions of  myeli- 
hated organ cultures. Data represent results from a single typical experiment with 5-8 cultures/group 
at each time point. Cultures were exposed to [14C]glucose alone (controls, © . . . .  ©), or [14C]glucose 
plus amide 5 (0.3 raM, ,'.. .......... /. ; 1.0 raM, • --•), on the 19th day after explant. 
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HOURS AFTER ADDITION OFAMIDE 5, lmM 
Fig. 4. Glucose incorporation into various fractions of  myelinated organ cultures exposed to 1 mM 
amide 5, expressed as percentage of  control values. Data represent the averages of  results from 4 to 5 
separate experiments at each time point, with standard deviations. 
Results of several experiments with the analog were compared by expressing 
glucose incorporation into the various fractions as a per cent of that observed in the 
control cultures in each experiment (Fig. 4). Again, some stimulation of non-lipid 
labeling, and the early depression of labeling of alkali-stable lipids were apparent. 
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TABLE V 
COMPARISON OF GLUCOSE INCORPORATION IN CULTURES WITH STRONG AND WEAK INHIBITORS OF CERE- 
BROSIDASE 
Cultures in the first experiment were harvested 36 h after the addition of the amides and the [l~C]glu- 
cose. In this experiment, the cultures with amides 1 and 2 appeared similar to the control at 36 h, with 
all cultures still well-myelinated as at the beginning of the experiment. Of the 5 cultures exposed to 
amide 3, one demyelinated between 18 and 36 h, and the remaining cultures all had swollen glial cells 
and lumpy myelin. In the second experiment, cultures were harvested at 4 h. when 7 of the 8 cultures 
exposed to amide 4 showed early signs of demyelination (primarily lumpy myelin). 
Amide Non-lipid Total lipids Cerebroside Cerebroside x 100 
pellet 
(counts/min/culture) Total lipid 
None 57,980 37,380 818 2.2 
1 (3 raM) 40,740 28,300 512 1.8 
2 (3 raM) 38,350 35,490 532 1.5 
3 (3 raM) 33,730 28,380 258 0.9 
None 10,072 8730 115 1.3 
4 (3 raM) 3836 4370 38 0.9 
TABLE VI 
GLUCOSE INCORPORATION IN CULTURES WITH AMIDE 5 (STRONG INHIBITOR OF CEREBROSIDASE) AND 
INHIBITORS OF PROTEIN SYNTHESIS 
At 4 h, all cultures appeared similar to controls. By 8 h, the cultures exposed to amide 5 had much 
distorted myelin although little demyelination had yet occurred; the cultures exposed to cycloheximide 
had some distorted myelin, and many sheaths appeared thinner, eventually 'melting away', while the 
cultures exposed to chloramphenicol showed little change. 
Addition Non-lipM Total Cerebroside Cerebroside 
pellet lipMs 
( counts/ min/ culture) Pellet 
/, 100 
4 h  
None 4970 5340 97 2.0 
Chloramphenicol 
(1 mM)  4360 4920 86 1.9 
Cycloheximide 
(0.3 raM) 1730 6300 90 5.2 
Amide 5 
(1 raM) 8400 5890 90 1. I 
8 h  
None 6920 4810 177 2.6 
Chloramphenicol 
(1 mM)  7020 5460 180 2.6 
Cycloheximide 
(0.3 raM) 3780 9350 413 10.9 
Amide 5 
(1 mM)  11,000 4150 131 1.2 
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Incorporation of glucosc into cerebroside was more depressed than into total iipids 
or alkali-labile lipids at 4 h. This analog has little effect on ceramide galactosyl 
transferase it* v i t ro  j 7. 
In another series of experiments, the 3-hydroxy derivatives, amides I and 2, had 
little effect on cerebroside labeling compared to total lipid, while the l-hydroxy 
derivatives, amides 3 and 4, caused a marked depression (Table V). This depression 
is again coincidental with early signs of demyelination, as with amide 5. Amides l 
and 2 were previously found to inhibit cerebroside synthesis2, iv but not cerebrosidase 
in v i t ro ,  while amides 3 and 4 inhibited both activities. 
The effects of the diol analog were compared to those of chloramphenicol and 
cycloheximide, known inhibitors of protein synthesis in mammalian mitochondria 
and endoplasmic reticulum, respectively. Chloramphenicol and the 1,3-propanediol 
analog (amide 5) were tested in the cultures at 1 mM, and cycloheximide at 0.3 raM. 
Cultures containing chloramphenicol showed no signs of demyelination up to 72 h, 
while those with cycloheximide and the analog were demyelinated by 24 and 48 h, 
respectively. Glucose incorporation was measured at the end of 4 h and 8 h (Table VI). 
With 1 mM chloramphenicol, we saw little effect on labeling of non-lipid, lipid or 
cerebroside fractions compared to controls. Cycloheximide strongly decreased non- 
lipid labeling, and by 8 h stimulated lipid labeling. As previously observed, the analog 
depressed labeling of lipids, including cerebroside, and stimulated non-lipid labeling 
at early time points. 
DISCUSSION 
Our observations in myelinating cultures indicate that inhibition or stimulation 
of cerebrosidase activity can inhibit myelination and cause demyelination. The strong 
correlations between degree of interference with myelin status and degree of inter- 
ference with cerebrosidase activity support the interpretation that this enzyme is the 
primary enzyme affected in the amide-treated cultures. Studies on the amides carried 
out subsequent to this study have shown that some of them have the additional ability 
to interfere with galactocerebroside synthesis 17. For  example, amide 7 acts as a com- 
petitive subs*rate for the rat brain galactosyltransferase, blocking eeramide utilization, 
so there is the possibility that this amide yielded sufficient abnormal myelin to cause 
interference with myelin metabolism. However amide 5 and the aliphatic amides, 
which also interfered effectively in myelination, have a minor effect on cerebroside 
synthesis, while amide 1, which inhibits cerebroside synthesis slightly, had no effect on 
myelin in the cultures for the periods studied. 
There are the additional possibilities that the amide analogs of ceramide acted 
on the cultures by virtue of ability to interfere with other sphingolipid enzymes or 
through non-specific toxic effects. However, it seems unlikely that the hypothetical 
interference could correlate so well with the observed order of effectiveness of the 
analogs. 
Our observations on the incorporation of labeled glucose into cerebroside, 
which showed a correlation between the reported degree of inhibition ofcerebrosidase 
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and degree of inhibition of cerebroside synthesis in the cultures, suggest that there is 
a tight coupling between cerebroside synthesis and degradation, and that excessive 
slowing seems to upset a fine balance needed to maintain myelin deposition. The 
same need for fine balance is seen in our finding that stimulation of cerebrosidase 
also induced demyelination. 
Only a few clues are available on the role of cerebrosidase in myelin deposition 
and maintenance 14. That  the enzyme acts in vivo is known from turnover studies, 
particularly the demonstration in young rats that there is a rapidly decaying pool of 
cerebroside following injection of labeled acetate 1~. That the enzyme is needed for 
normal brain development, particularly myelin deposition, is evident from the relation- 
ship of the enzyme to the pathology of Krabbe's disease~L Possibly the enzyme 
functions during myelination to 'remodel' the winding membrane or to eliminate 
'internodal crowding '5. 
Evidence for a significant role for cerebrosidase in the maintenance of myelin 
comes from the observation s that the specific activity of the enzyme in rat brain rises 
4-fold between 7 and 24 days and drops only slightly in adulthood. In contrast, the 
enzyme which synthesizes cerebroside 9 and the enzymes which synthesizO 3 and 
degrade TM cerebroside sulfate also increase markedly during active myelin deposition, 
yet decrease considerably when the period of rapid myelination ends. 
When we examined the overall metabolic effects of amide 5, one of the strong 
inhibitors of cerebrosidase, we observed depressed incorporation of [14C]glucose 
into alkali-stable lipids, including cerebroside, before labeling of other lipids was 
markedly affected. The alkali-stable lipid fraction includes galactolipids, sphingo- 
myelin and lysoplasmalogens, all enriched in myelin, and depressed incorporation 
of glucose into these lipids may indicate early damage to oligodendroglial and myelin 
metabolism. The early stimulation of incorporation of [14C]glucose into protein in 
our experiments may simply reflect decreased utilization of carbohydrate for lipid 
synthesis, or some more specific effect. The decreased labeling seen in all fractions 
by 36 h in demyelinating cultures may be a combination of fewer viable cells to 
incorporate [14C]glucose, and degradation of some components labeled earlier. 
We also altered the metabolism of the cultures by inhibiting protein synthesis 
with cycloheximide. Demyelination occurred, followed by degeneration of all cell 
types. The metabolic effects were different from those observed with inhibition of 
cerebrosidase, with decreased incorporation of glucose into proteins, and increased 
incorporation into all lipids, including cerebroside and other alkali-stable lipids. 
Chloramphenicol was tested because it bears a structural resemblance to the pro- 
panediol analogs; Arora and Radin 3 previously reported it had no effect on cerebro- 
sidase activity, and we found no effects on cerebroside metabolism in the cultures. 
Smith and Hasinoff 2° reported that chloramphenicol inhibits both lipid and protein 
synthesis in brain slices at a concentration of 5 raM. We saw no effect on total lipid 
or protein synthesis in the cultures at a 5-fold lower concentration. 
The demyelination we observed with the analogs was similar to that described 
in cultures exposed to sera from rabbits with experimental allergic encephalomyelitis 
(induced by injection of whole spinal cord) 6 or to sera from patients with multiple 
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sclerosis L~. That  is. d is tor ted myelin and glial swelling were the lirst signs or' abnor-  
mali ty,  with neurons,  axons and ependymal  cells appear ing  normal  until the late 
stages of  demyel ina t ion .  Unlike the experhnents  with sera, we did see abnormalitic,~ 
in large neurons with higher concent ra t ions  (1-3 raM) o f  the more  potent  analogs.  
Axon  preserva t ion  was seen al~er dcmyel inat ion ,  as noted by Si lberberg m cultures 
exposed to some metabol i tes  of  pheny lke tonur ia  is. Except  in the case of  amidc  5 
(s t rongest  inhibi tor  of  cerebros idase)  in younger  cultures,  we did not see rapid 
vacuol iza t ion  or  death  of  the cultures.  Nor  did we observe the spherical "beaded'  
myelin figures apparen t ly  caused by low glucose in the medium v'. 
The ceramide  analogs which inhibi t  or  s t imulate  cerebros idase  are potent ia l ly  
tools  for de te rmin ing  the role of  cerebros ide  degrada t ion  in myel ina l ion  and in the 
metabo l ic  economy of  the cell. More  specifically, some of  the inhibi tory analogs may 
prov ide  a model  of  K r a b b e ' s  disease, in cul ture and possibly  in vivo. Finally,  glucose 
inco rpora t ion  into various fract ions appears  to be a useful technique for de termining  
the specific metabo l ic  effects o f  various demyel ina t ing  agents added  to organ cultures.  
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